Connection

LAURA PETERSEN to Veterans Health

This is a "connection" page, showing publications LAURA PETERSEN has written about Veterans Health.
Connection Strength

2.776
  1. Determinants of referral network size for screening colonoscopies in the Veterans Health Administration after the implementation of the MISSION Act. Health Serv Res. 2024 02; 59(1):e14239.
    View in: PubMed
    Score: 0.768
  2. Veterans Health Administration enrollees' choice of care setting relates to the expansion of care options: Evidence from screening colonoscopies before and after the MISSION Act. Health Serv Res. 2024 02; 59(1):e14241.
    View in: PubMed
    Score: 0.768
  3. A Novel Method for Assessing Task Complexity in Outpatient Clinical-Performance Measures. J Gen Intern Med. 2016 Apr; 31 Suppl 1:28-35.
    View in: PubMed
    Score: 0.457
  4. Nurse Leader Perceptions of Data in the Veterans Health Administration: A Qualitative Evaluation. Comput Inform Nurs. 2023 Sep 01; 41(9):679-686.
    View in: PubMed
    Score: 0.191
  5. Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease. Circ Cardiovasc Qual Outcomes. 2019 01; 12(1):e004817.
    View in: PubMed
    Score: 0.138
  6. Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1842-1850.
    View in: PubMed
    Score: 0.137
  7. Health Care Resource Utilization for Outpatient Cardiovascular Disease and Diabetes Care Delivery Among Advanced Practice Providers and Physician Providers in Primary Care. Popul Health Manag. 2018 06; 21(3):209-216.
    View in: PubMed
    Score: 0.127
  8. Statin Use and Its Facility-Level Variation in Patients With Diabetes: Insight From the Veterans Affairs National Database. Clin Cardiol. 2016 Apr; 39(4):185-91.
    View in: PubMed
    Score: 0.114
  9. Statin Prescription Rates, Adherence, and Associated Clinical Outcomes Among Women with PAD and ICVD. Cardiovasc Drugs Ther. 2020 12; 34(6):745-754.
    View in: PubMed
    Score: 0.039
  10. Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial. Circulation. 2019 01 15; 139(3):410-412.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.